Arcadia Biosciences (RKDA) Operating Expenses (2014 - 2025)

Arcadia Biosciences' Operating Expenses history runs 12 years deep, the most recent figure standing at $2.3 million for Q4 2025.

• Quarterly Operating Expenses fell 34.88% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.4 million (down 15.38% YoY) and the FY2025 annual result came in at $7.4 million, down 15.36% from the prior year.
• Operating Expenses was $2.3 million for Q4 2025 at Arcadia Biosciences, down from $2.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $16.0 million in Q4 2021 and bottomed at -$2.0 million in Q4 2023.
• A 5-year average of $4.7 million and a median of $3.4 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2021 — Operating Expenses surged 4812.39% — and 2023, when it sank 136.65%.
• Arcadia Biosciences' Operating Expenses stood at $16.0 million in 2021, then slumped by 66.18% to $5.4 million in 2022, then sank by 136.65% to -$2.0 million in 2023, then jumped by 276.52% to $3.5 million in 2024, then slumped by 34.88% to $2.3 million in 2025.
• Business Quant data shows RKDA's Operating Expenses at $2.3 million in Q4 2025, $2.5 million in Q3 2025, and $2.0 million in Q2 2025.